These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19589012)

  • 21. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
    Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR
    Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study.
    Rome BN; Gagne JJ; Avorn J; Kesselheim AS
    Am Heart J; 2021 Mar; 233():109-121. PubMed ID: 33358690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication adherence changes following value-based insurance design.
    Farley JF; Wansink D; Lindquist JH; Parker JC; Maciejewski ML
    Am J Manag Care; 2012 May; 18(5):265-74. PubMed ID: 22694064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway.
    Devold HM; Furu K; Skurtveit S; Tverdal A; Falch JA; Sogaard AJ
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):297-304. PubMed ID: 22237942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonadherence to antiepileptic drugs in Germany: A retrospective, population-based study.
    Gollwitzer S; Kostev K; Hagge M; Lang J; Graf W; Hamer HM
    Neurology; 2016 Aug; 87(5):466-72. PubMed ID: 27371490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study.
    Chen L; Li C; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Qian J
    Curr Med Res Opin; 2020 Sep; 36(9):1533-1540. PubMed ID: 32644886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of generic imatinib may improve medication adherence for patients with chronic myeloid leukemia.
    Cole AL; Jazowski SA; Dusetzina SB
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1529-1533. PubMed ID: 31507005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance after switching from branded to generic statins.
    Romanelli RJ; Jukes T; Segal JB
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1093-100. PubMed ID: 24817435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.
    Shin S; Song H; Oh SK; Choi KE; Kim H; Jang S
    Hypertens Res; 2013 Nov; 36(11):1000-5. PubMed ID: 23966057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.
    Ude M; Schuessel K; Quinzler R; Leuner K; Müller WE; Schulz M
    J Hypertens; 2011 Sep; 29(9):1837-45. PubMed ID: 21738055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
    Baggarly SA; Kemp RJ; Wang X; Magoun AD
    Res Social Adm Pharm; 2014; 10(6):e99-e112. PubMed ID: 24731547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
    Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study.
    Han E; Suh DC; Lee SM; Jang S
    Res Social Adm Pharm; 2014; 10(6):e87-e98. PubMed ID: 25088545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of partial reimbursement on hepatitis B antiviral utilization and adherence.
    Qiu Q; Duan XW; Li Y; Yang LK; Chen Y; Li H; Duan ZP; Wang L
    World J Gastroenterol; 2015 Aug; 21(32):9588-97. PubMed ID: 26327766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.
    Rodin HA; Heaton AH; Wilson AR; Garrett NA; Plocher DW
    Am J Manag Care; 2009 Dec; 15(12):881-8. PubMed ID: 20001169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive medication adherence and subsequent healthcare utilization and costs.
    Pittman DG; Tao Z; Chen W; Stettin GD
    Am J Manag Care; 2010 Aug; 16(8):568-76. PubMed ID: 20712390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.
    Calip GS; Xing S; Jun DH; Lee WJ; Hoskins KF; Ko NY
    J Oncol Pract; 2017 May; 13(5):e451-e462. PubMed ID: 28287854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer.
    Winn AN; Fergestrom NM; Neuner JM
    Med Care; 2019 Jan; 57(1):85-93. PubMed ID: 30489546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.